Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage.
Journal: Scientific reports
Published: June 09, 2017
Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury.
Journal: Scientific reports
Published: April 15, 2016
PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
Journal: Journal of hepatology
Published: February 12, 2016
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity.
Journal: British journal of pharmacology
Published: March 18, 2015
Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.
Journal: Molecular medicine (Cambridge, Mass.)
Published: December 22, 2014
Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis.
Journal: Hepatology (Baltimore, Md.)
Published: April 18, 2013
Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.
Journal: Gastroenterology
Published: August 02, 2012
Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants.
Journal: Free radical biology & medicine
Published: January 19, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026